DAFNA Capital Management sold 265,456 shares of Axogen (AXGN) in Q4, an estimated transaction value of $6.53 million based on quarterly average prices. The report is a routine institutional disposition with no company-specific news or guidance attached. Likely reflects portfolio rebalancing and is unlikely to materially move AXGN absent other catalysts.
DAFNA Capital Management sold 265,456 shares of Axogen (AXGN) in Q4, an estimated transaction value of $6.53 million based on quarterly average prices. The report is a routine institutional disposition with no company-specific news or guidance attached. Likely reflects portfolio rebalancing and is unlikely to materially move AXGN absent other catalysts.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
